We are live on ! Find out more
PYPD icon

PolyPid

8 hedge funds and large institutions have $5.13M invested in PolyPid in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

6,089% more capital invested

Capital invested by funds: $82.9K → $5.13M (+$5.05M)

60% more funds holding

Funds holding: 58 (+3)

21.59% more ownership

Funds ownership: 1.33%22.92% (+22%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ACM
1
AIGH Capital Management
Maryland
$2.27M +$2.9M +479,246 New
RA
2
Rosalind Advisors
Ontario, Canada
$1.91M +$2.51M +415,800 New
DCM
3
DAFNA Capital Management
California
$853K +$1.12M +185,446 New
YLHM
4
Yelin Lapidot Holdings Management
Israel
$51.3K
SPIA
5
Steward Partners Investment Advisory
New York
$33.8K
Morgan Stanley
6
Morgan Stanley
New York
$4.04K -$5.3K -878 -50%
Osaic Holdings
7
Osaic Holdings
Arizona
$2.15K -$2.01K -333 -42%
UBS Group
8
UBS Group
Switzerland
$87 -$4.5K -745 -98%

PYPD Hedge Fund Activity: Q1 2024 in Review

8 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in PolyPid (PYPD) for Q1 2024, worth a combined $5.13M — up 6,089% from $82.9K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new PYPD positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 3 trimmed.

The largest buyer was AIGH Capital Management, opening a new position worth an estimated $2.9M. The largest seller was Morgan Stanley, cutting an estimated $5.3K.

  • 8 institutional investors held PolyPid (PYPD) as of Q1 2024, up from 5 in Q4 2023.
  • Funds reported $5.13M of PolyPid stock for Q1 2024, up 6,089% quarter-over-quarter.
  • 3 funds opened new PolyPid positions in Q1 2024 and 0 closed out, a net change of +3 holders.
  • The largest PolyPid buyer in Q1 2024 was AIGH Capital Management, an estimated $2.9M added.
  • The largest PolyPid seller in Q1 2024 was Morgan Stanley, an estimated $5.3K sold.

Based on aggregated 13F filings for Q1 2024.